Cargando…
Enhanced Anti-lymphoma Activity of CAR19-iNKT Cells Underpinned by Dual CD19 and CD1d Targeting
Chimeric antigen receptor anti-CD19 (CAR19)-T cell immunotherapy-induced clinical remissions in CD19(+) B cell lymphomas are often short lived. We tested whether CAR19-engineering of the CD1d-restricted invariant natural killer T (iNKT) cells would result in enhanced anti-lymphoma activity. CAR19-iN...
Autores principales: | Rotolo, Antonia, Caputo, Valentina S., Holubova, Monika, Baxan, Nicoleta, Dubois, Olivier, Chaudhry, Mohammed Suhail, Xiao, Xiaolin, Goudevenou, Katerina, Pitcher, David S., Petevi, Kyriaki, Kachramanoglou, Carolina, Iles, Sandra, Naresh, Kikkeri, Maher, John, Karadimitris, Anastasios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cell Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6179961/ https://www.ncbi.nlm.nih.gov/pubmed/30300581 http://dx.doi.org/10.1016/j.ccell.2018.08.017 |
Ejemplares similares
-
CD8(+) T-cell immunity orchestrated by iNKT cells
por: Qin, Yingyu, et al.
Publicado: (2023) -
c-Myb primes CD4(+)CD8(+) immature thymocytes for selection into the iNKT lineage
por: Hu, Taishan, et al.
Publicado: (2010) -
NKT10 cells: a novel iNKT cell subset
por: Wingender, Gerhard, et al.
Publicado: (2015) -
Constitutive CD8 expression drives innate CD8(+) T-cell differentiation via induction of iNKT2 cells
por: Kojo, Satoshi, et al.
Publicado: (2020) -
Activated iNKT Cells Promote Memory CD8(+) T Cell Differentiation during Viral Infection
por: Reilly, Emma C., et al.
Publicado: (2012)